9-136377605-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003086.4(SNAPC4):c.4222G>A(p.Glu1408Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000454 in 1,541,872 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_003086.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SNAPC4 | NM_003086.4 | c.4222G>A | p.Glu1408Lys | missense_variant | 22/24 | ENST00000684778.1 | NP_003077.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SNAPC4 | ENST00000684778.1 | c.4222G>A | p.Glu1408Lys | missense_variant | 22/24 | NM_003086.4 | ENSP00000510559.1 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152240Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.00000981 AC: 2AN: 203932Hom.: 0 AF XY: 0.0000182 AC XY: 2AN XY: 110072
GnomAD4 exome AF: 0.00000360 AC: 5AN: 1389632Hom.: 0 Cov.: 35 AF XY: 0.00000586 AC XY: 4AN XY: 683006
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152240Hom.: 0 Cov.: 34 AF XY: 0.0000134 AC XY: 1AN XY: 74364
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 10, 2024 | The c.4222G>A (p.E1408K) alteration is located in exon 21 (coding exon 21) of the SNAPC4 gene. This alteration results from a G to A substitution at nucleotide position 4222, causing the glutamic acid (E) at amino acid position 1408 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at